Source: Annual Congress 2011 - Macrophage heterogeneity in respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Melgert (Groningen, Netherlands). Alternativeley activated macrophages as cause or effect in asthma. Annual Congress 2011 - Macrophage heterogeneity in respiratory diseases

Member's Comments

No comment yet.

Related content which might interest you: Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in COPD Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 The influence of allergen challenge on apoptosis and CD-95 receptor level in induced sputum cells from children with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 6s Year: 2002 Mast cell generated cyclooxygenase products protect from airway hyperresponsiveness in a model of chronic asthma Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011 Gamma/delta T cells regulate airways disease during rhinovirus-induced asthma exacerbations Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001 Distinct effect of IRAK-M on airway inflammation induced by exposure to LPS or cigarette smoking Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017 The effect of GSK2190915, a 5-lipoxygenase activating protein inhibitor, on the allergen induced asthmatic response Source: Annual Congress 2011 - New treatments for airway disease Year: 2011 Induction of pro-inflammatory mediator release by cigarette smoke condensate: differential effects on alveolar epithelial cells and macrophages Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003 Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 Farm dust decreases Th2 driven allergic airway inflammation in mice: A role for airway TLR2 and TLR4? Source: Annual Congress 2011 - T-cell subsets Year: 2011 Cigarette smoke can increase the neutrophil recruitment in the airways of COPD patients by increasing PGE2 release in alveolar macrophages (AM) Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003 CCL6 produced by eosinophils drives allergic airway inflammation in mice Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Rhinovirus triggers increased inflammasome activation in human bronchial epithelium in asthma. Source: International Congress 2017 – Infection and exacerbation science Year: 2017 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Small molecular inhibition of TSLP production in primary asthmatic bronchial epithelial cells Source: Annual Congress 2010 - Immune modulation of airways diseases Year: 2010 The influence of gluco-corticoids (GC) on the apoptosis of activated cells in the induced sputum of patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002 Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011